Thymidine Analogues As Potent Tk-2 Inhibitors

Thymidine Analogues As Potent Tk-2 Inhibitors

SYNTHESIS AND BIOLOGICAL EVALUATION OF PYRIMIDINE NUCLEOSIDES AND NUCLEOSIDE PHOSPHONATES Apr. Sara Van Poecke Promoter Prof. Dr. Apr. Serge Van Calenbergh Academic year 2011-2012 SYNTHESIS AND BIOLOGICAL EVALUATION OF PYRIMIDINE NUCLEOSIDES AND NUCLEOSIDE PHOSPHONATES Apr. Sara Van Poecke Thesis submitted to the Faculty of Pharmaceutical Sciences to obtain the degree of Doctor in Pharmaceutical Sciences Promoter Prof. Dr. Apr. Serge Van Calenbergh Academic year 2011-2012 TABLE OF CONTENTS PART I: 3’-MODIFIED THYMIDINE ANALOGUES AS POTENT TK-2 INHIBITORS ........................... 1 Chapter 1: INTRODUCTION ................................................................................................................... 3 1.1 DEOXYRIBONUCLEOTIDES ................................................................................................... 3 1.1.1 The de novo Pathway ........................................................................................................ 4 1.1.2 Salvage Pathway ............................................................................................................... 4 1.2 DEOXYNUCLEOSIDE KINASES .............................................................................................. 4 1.3 THYMIDINE KINASES (TK-2 VS. TK-1)..................................................................................... 5 1.3.1 Localization and Expression .............................................................................................. 5 1.3.2 Substrate Specificities ....................................................................................................... 6 1.3.3 Structure ............................................................................................................................ 8 1.3.4 Mechanism of Action ....................................................................................................... 10 1.4 THE ROLE OF TK-2 ................................................................................................................ 11 1.4.1 mtDNA Synthesis ............................................................................................................. 11 1.4.2 TK-2 Deficiency ................................................................................................................ 12 1.5 TK-2 INHIBITORS ................................................................................................................... 15 1.5.1 Role of TK-2 Inhibitors ..................................................................................................... 15 1.5.2 Structure of TK-2 Inhibitors .............................................................................................. 15 Chapter 2: SYNTHESIS AND BIOLOGICAL EVALUATION OF 3’-TRIAZOLE-SUBSTITUTED THYMIDINE AND BVDU DERIVATIVES .............................................................................................. 21 2.1 OBJECTIVES .......................................................................................................................... 21 2.2 CHEMISTRY ........................................................................................................................... 23 2.2.1 Synthesis of 3’-Triazole-Substituted Thymidine Analogues ............................................ 23 2.2.2 Synthesis of 5’-O-Protected Isothiocyanate Analogue 1.59 ............................................ 25 2.2.3 Synthesis of 3’-Triazole-Substituted BVDU Analogues ................................................... 25 2.3 BIOLOGICAL EVALUATION ................................................................................................... 27 2.4 MOLECULAR MODELING AND STRUCTURE-ACTIVITY RELATIONSHIP ......................... 30 2.5 PHOTOPHYSICAL EVALUATION .......................................................................................... 34 2.6 CONCLUSIONS ...................................................................................................................... 35 2.7 EXPERIMENTAL PART .......................................................................................................... 36 2.7.1 Synthesis ......................................................................................................................... 36 2.7.2 Experimental Assays ....................................................................................................... 52 vii Chapter 3: SYNTHESIS AND BIOLOGICAL EVALUATION OF 3’-GUANIDINE-SUBSTITUTED THYMIDINE AND BVDU DERIVATIVES .............................................................................................. 55 3.1 OBJECTIVES .......................................................................................................................... 55 3.2 CHEMISTRY ........................................................................................................................... 56 3.2.1 Synthesis of 3’-Benzylamino Analogues of Thymidine .................................................... 56 3.2.2 Synthesis of 3’-Guanidine and 3’-Aminotetrazole Analogues of Thymidine .................... 56 3.2.3 Synthesis of 3’-Aminotetrazole Analogues of BVDU ....................................................... 60 3.3 BIOLOGICAL EVALUATION ................................................................................................... 61 3.4 MOLECULAR MODELING ...................................................................................................... 63 3.5 CONCLUSIONS ...................................................................................................................... 64 3.6 EXPERIMENTAL PART .......................................................................................................... 65 3.6.1 Synthesis ......................................................................................................................... 65 Part II: FURTHER EXPLORATION OF THE S.A.R. OF SUBSTRATE-BASED M. tuberculosis TMPK INHIBITORS ............................................................................................................................... 85 Chapter 1: INTRODUCTION ................................................................................................................. 87 1.1 TUBERCULOSIS .................................................................................................................... 89 1.1.1 Causative Organisms ...................................................................................................... 89 1.1.2 Transmission .................................................................................................................... 90 1.1.3 Pathophysiology............................................................................................................... 90 1.1.4 Symptoms ........................................................................................................................ 91 1.1.5 Diagnosis ......................................................................................................................... 92 1.1.6 Prevention and Control .................................................................................................... 93 1.1.7 Treatment ......................................................................................................................... 94 1.1.8 Resistance ....................................................................................................................... 97 1.2 THYMIDINE MONOPHOSPHATE KINASE (TMPK) ............................................................. 100 1.2.1 Structure of TMPKmt ..................................................................................................... 100 1.2.2 Known TMPKmt Inhibitors ............................................................................................. 102 Chapter 2: SYNTHESIS AND INHIBITORY ACTIVITY OF THYMIDINE ANALOGUES TARGETING TMPKmt ............................................................................................................................................... 107 2.1 OBJECTIVES ........................................................................................................................ 107 2.2 CHEMISTRY ......................................................................................................................... 110 2.2.1 Synthesis of 3’-Modified 4-Thio-β-Thymidine Analogues .............................................. 110 2.2.2 Synthesis of 5’-Modified β-Thymidine Analogues.......................................................... 111 2.2.3 Synthesis of 5’-Modified (4-Thio-)α-Thymidine Analogues ............................................ 113 2.2.4 Synthesis of 3’-Modified α-Thymidine Analogues.......................................................... 115 2.3 BIOLOGICAL EVALUATION ................................................................................................. 116 2.4 MOLECULAR DOCKING ...................................................................................................... 118 2.5 CONCLUSIONS .................................................................................................................... 119 viii 2.6 EXPERIMENTAL PART ........................................................................................................ 120 2.6.1 Synthesis ....................................................................................................................... 120 2.6.2 Biological Assays ..........................................................................................................

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    300 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us